These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 23279712)
1. Prevalence of multiple sclerosis in Verona, Italy: an epidemiological and genetic study. Gajofatto A; Stefani A; Turatti M; Bianchi MR; Lira MG; Moretto G; Salviati A; Benedetti MD Eur J Neurol; 2013 Apr; 20(4):697-703. PubMed ID: 23279712 [TBL] [Abstract][Full Text] [Related]
2. Relationship between HLA-DRB1* 11/15 genotype and susceptibility to multiple sclerosis in Iran. Abolfazli R; Samadzadeh S; Sabokbar T; Siroos B; Armaki SA; Aslanbeiki B; Ghelman M; Taheri T; Shakoori A J Neurol Sci; 2014 Oct; 345(1-2):92-6. PubMed ID: 25064442 [TBL] [Abstract][Full Text] [Related]
3. Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II. Ouadghiri S; El Alaoui Toussi K; Brick C; Ait Benhaddou EH; Benseffaj N; Benomar A; El Yahyaoui M; Essakalli M Pathol Biol (Paris); 2013 Dec; 61(6):259-63. PubMed ID: 23849771 [TBL] [Abstract][Full Text] [Related]
4. HLA-DRB1*15:01 and multiple sclerosis: a female association? Irizar H; Muñoz-Culla M; Zuriarrain O; Goyenechea E; Castillo-Triviño T; Prada A; Saenz-Cuesta M; De Juan D; Lopez de Munain A; Olascoaga J; Otaegui D Mult Scler; 2012 May; 18(5):569-77. PubMed ID: 22127897 [TBL] [Abstract][Full Text] [Related]
5. A sequence variation in the MOG gene is involved in multiple sclerosis susceptibility in Italy. D'Alfonso S; Bolognesi E; Guerini FR; Barizzone N; Bocca S; Ferrante D; Castelli L; Bergamaschi L; Agliardi C; Ferrante P; Naldi P; Leone M; Caputo D; Ballerini C; Salvetti M; Galimberti D; Massacesi L; Trojano M; Momigliano-Richiardi P Genes Immun; 2008 Jan; 9(1):7-15. PubMed ID: 17928868 [TBL] [Abstract][Full Text] [Related]
6. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals. Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634 [TBL] [Abstract][Full Text] [Related]
7. Latitude and HLA-DRB1*04:05 independently influence disease severity in Japanese multiple sclerosis: a cross-sectional study. Nakamura Y; Matsushita T; Sato S; Niino M; Fukazawa T; Yoshimura S; Hisahara S; Isobe N; Shimohama S; Watanabe M; Yoshida K; Houzen H; Miyazaki Y; Yamasaki R; Kikuchi S; Kira J; J Neuroinflammation; 2016 Sep; 13(1):239. PubMed ID: 27599848 [TBL] [Abstract][Full Text] [Related]
9. The CIITA genetic polymorphism rs4774*C in combination with the HLA-DRB1*15:01 allele as a putative susceptibility factor to multiple sclerosis in Brazilian females. Paradela ER; Alves-Leon SV; Figueiredo AL; Pereira VC; Malfetano F; Mansur LF; Scherpenhuijzen S; Agostinho LA; Rocha CF; Rueda-Lopes F; Gasparetto E; Paiva CL Arq Neuropsiquiatr; 2015 Apr; 73(4):283-8. PubMed ID: 25992516 [TBL] [Abstract][Full Text] [Related]
10. The HLA-DRB1 risk alleles for multiple sclerosis are differentially expressed in blood cells of patients from Southern Italy. Pisapia L; Cerillo I; Farina F; Zimbardo A; Barba P; Orefice G; Gianfrani C; Strazzullo M; Del Pozzo G Int J Immunogenet; 2019 Dec; 46(6):479-484. PubMed ID: 31313885 [TBL] [Abstract][Full Text] [Related]
11. Genetic association of HLA-DQB1 and HLA-DRB1 polymorphisms with alopecia areata in the Italian population. Megiorni F; Pizzuti A; Mora B; Rizzuti A; Garelli V; Maxia C; Carlesimo M; Fotruna MC; Delle Chiaie R; Cavaggioni G; Rossi A Br J Dermatol; 2011 Oct; 165(4):823-7. PubMed ID: 21692766 [TBL] [Abstract][Full Text] [Related]
12. Gender influence in EBV antibody response in multiple sclerosis patients from Kuwait. Al-Temaimi R; Alroughani R; Jacob S; Al-Mulla F J Neuroimmunol; 2015 Aug; 285():57-61. PubMed ID: 26198919 [TBL] [Abstract][Full Text] [Related]
13. Interaction of HLA-DRB1*1501 allele and TNF-alpha -308 G/A single nucleotide polymorphism in the susceptibility to multiple sclerosis. Shahbazi M; Roshandel D; Omidnyia E; Rshaidbaghan A Clin Immunol; 2011 Jun; 139(3):277-81. PubMed ID: 21396892 [TBL] [Abstract][Full Text] [Related]
14. The association of -330 interleukin-2 gene polymorphism and HLA-DR15 allele in Iranian patients with multiple sclerosis. Sayad A Int J Immunogenet; 2014 Aug; 41(4):330-4. PubMed ID: 24919928 [TBL] [Abstract][Full Text] [Related]
15. Association of HLA-DRB1*15 allele and CSF oligoclonal bands in a Spanish multiple sclerosis cohort. Romero-Pinel L; Martínez-Yélamos S; Bau L; Matas E; Gubieras L; María Pujal J; Morandeira F; Bas J; Arbizu T Eur J Neurol; 2011 Oct; 18(10):1258-62. PubMed ID: 21418440 [TBL] [Abstract][Full Text] [Related]
16. ALCAM--novel multiple sclerosis locus interfering with HLA-DRB1*1501. Wagner M; Wiśniewski A; Bilińska M; Pokryszko-Dragan A; Nowak I; Kuśnierczyk P; Jasek M J Neuroimmunol; 2013 May; 258(1-2):71-6. PubMed ID: 23507476 [TBL] [Abstract][Full Text] [Related]
17. The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population. Silva AM; Pereira C; Bettencourt A; Carvalho C; Couto AR; Leite MI; Marta M; Freijo M; Costa PP; Mendonça D; Monteiro L; Armas JB; Martins B J Neurol Sci; 2007 Jul; 258(1-2):69-74. PubMed ID: 17412364 [TBL] [Abstract][Full Text] [Related]
18. The influence of combined genotypes of the HLADRB1*1501 and CD24 single nucleotide polymorphism on disease severity of Iranian multiple sclerosis patients. Ghlichnia HA; Kollaee A; Gaffarpoor M; Movafagh A; Ghlichnia B; Zamani M Acta Med Iran; 2014; 52(6):418-23. PubMed ID: 25130147 [TBL] [Abstract][Full Text] [Related]
19. HLA-A confers an HLA-DRB1 independent influence on the risk of multiple sclerosis. Brynedal B; Duvefelt K; Jonasdottir G; Roos IM; Akesson E; Palmgren J; Hillert J PLoS One; 2007 Jul; 2(7):e664. PubMed ID: 17653284 [TBL] [Abstract][Full Text] [Related]
20. A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese. Huang J; Yoshimura S; Isobe N; Matsushita T; Yonekawa T; Sato S; Yamasaki R; Kira J; Mult Scler; 2013 Nov; 19(13):1696-703. PubMed ID: 23549433 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]